These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27737600)
21. Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder. McIntyre RS; Cha DS; Jerrell JM; Swardfager W; Kim RD; Costa LG; Baskaran A; Soczynska JK; Woldeyohannes HO; Mansur RB; Brietzke E; Powell AM; Gallaugher A; Kudlow P; Kaidanovich-Beilin O; Alsuwaidan M Bipolar Disord; 2014 Aug; 16(5):531-47. PubMed ID: 24330342 [TBL] [Abstract][Full Text] [Related]
22. Further development of biomarkers in amyotrophic lateral sclerosis. Blasco H; Vourc'h P; Pradat PF; Gordon PH; Andres CR; Corcia P Expert Rev Mol Diagn; 2016 Aug; 16(8):853-68. PubMed ID: 27275785 [TBL] [Abstract][Full Text] [Related]
23. Dysregulation of the NF-κB pathway as a potential inducer of bipolar disorder. Elhaik E; Zandi P J Psychiatr Res; 2015 Nov; 70():18-27. PubMed ID: 26424419 [TBL] [Abstract][Full Text] [Related]
24. The Neurobiology of Bipolar Disorder. Young AH; Juruena MF Curr Top Behav Neurosci; 2021; 48():1-20. PubMed ID: 33442840 [TBL] [Abstract][Full Text] [Related]
25. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453 [TBL] [Abstract][Full Text] [Related]
26. Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Goldstein BI; Young LT Curr Psychiatry Rep; 2013 Dec; 15(12):425. PubMed ID: 24243532 [TBL] [Abstract][Full Text] [Related]
27. Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types. Dacquino C; De Rossi P; Spalletta G Clin Chim Acta; 2015 Sep; 449():49-59. PubMed ID: 25704299 [TBL] [Abstract][Full Text] [Related]
28. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Phillips ML; Vieta E Schizophr Bull; 2007 Jul; 33(4):893-904. PubMed ID: 17562698 [TBL] [Abstract][Full Text] [Related]
29. The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder. Kim HK; Chen W; Andreazza AC Neural Plast; 2015; 2015():408136. PubMed ID: 26075098 [TBL] [Abstract][Full Text] [Related]
30. [MicroRNAs in bipolar disorder: diagnostic and therapeutic applications]. Suárez-Gómez M; Alejandre-Durán E; Ruiz-Rubio M Rev Neurol; 2011 Jul; 53(2):91-8. PubMed ID: 21720979 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Chang CC; Jou SH; Lin TT; Liu CS Psychiatry Clin Neurosci; 2014 Jul; 68(7):551-7. PubMed ID: 24447331 [TBL] [Abstract][Full Text] [Related]
32. [Predictors of prophylactic response to lithium]. Rohayem J; Baylé JF; Richa S Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242 [TBL] [Abstract][Full Text] [Related]
33. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391 [TBL] [Abstract][Full Text] [Related]
34. Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics. Sussulini A; Prando A; Maretto DA; Poppi RJ; Tasic L; Banzato CE; Arruda MA Anal Chem; 2009 Dec; 81(23):9755-63. PubMed ID: 19863109 [TBL] [Abstract][Full Text] [Related]
35. Peripheral biomarkers and illness activity in bipolar disorder. Kapczinski F; Dal-Pizzol F; Teixeira AL; Magalhaes PV; Kauer-Sant'Anna M; Klamt F; Moreira JC; de Bittencourt Pasquali MA; Fries GR; Quevedo J; Gama CS; Post R J Psychiatr Res; 2011 Feb; 45(2):156-61. PubMed ID: 20541770 [TBL] [Abstract][Full Text] [Related]
36. Functional neuroimaging studies of bipolar disorder: examining the wide clinical spectrum in the search for disease endophenotypes. Pan L; Keener MT; Hassel S; Phillips ML Int Rev Psychiatry; 2009; 21(4):368-79. PubMed ID: 20374150 [TBL] [Abstract][Full Text] [Related]
37. [Circadian markers and genes in bipolar disorder]. Yeim S; Boudebesse C; Etain B; Belliviera F Encephale; 2015 Sep; 41(4 Suppl 1):S38-44. PubMed ID: 26746321 [TBL] [Abstract][Full Text] [Related]
38. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Potash JB; Willour VL; Chiu YF; Simpson SG; MacKinnon DF; Pearlson GD; DePaulo JR; McInnis MG Am J Psychiatry; 2001 Aug; 158(8):1258-64. PubMed ID: 11481160 [TBL] [Abstract][Full Text] [Related]
39. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population. Roh MS; Lee KY; Joo EJ; Lee N; Kim YS Neurosci Lett; 2007 Oct; 427(1):1-5. PubMed ID: 17928143 [TBL] [Abstract][Full Text] [Related]
40. Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: A review of neuroimaging studies of individuals at high genetic risk for bipolar disorder. Nery FG; Monkul ES; Lafer B Aust N Z J Psychiatry; 2013 Dec; 47(12):1124-35. PubMed ID: 23864160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]